Last reviewed · How we verify
Observation arm
An observation arm is a non-interventional study group used to monitor natural disease progression or outcomes without active drug treatment.
At a glance
| Generic name | Observation arm |
|---|---|
| Also known as | Therapeutic entecavir group |
| Sponsor | PENG YUAN |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
An observation arm serves as a control or comparator group in clinical trials where patients are followed prospectively to document disease course, standard care patterns, and outcomes without receiving the investigational drug. This allows researchers to establish baseline natural history and compare it against treated populations.
Approved indications
Common side effects
Key clinical trials
- Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy (PHASE3)
- Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial (PHASE3)
- Assisted Identification and Navigation of Early Mental Health Symptoms in Children (NA)
- Cera™ Vascular Plug System Post-Market Clinical Follow-Up
- Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer (PHASE3)
- IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes (PHASE3)
- Comparison of Non-Invasive Mean Arterial Blood Pressure Measurements at the Arm and Ankle During Elective Cesarean Delivery.
- Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |